A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Pleural Mesothelioma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Morphotek, Inc
Start Date
April 1, 2016
End Date
April 30, 2016
Administered By
Duke Cancer Institute
Awarded By
Morphotek, Inc
Start Date
April 1, 2016
End Date
April 30, 2016